Skip to content

Our Mission

Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases.

Experienced Leadership Team

Miles Suk

Miles Suk

 CEO, Chairman

Robert Markelewicz, MD

Robert Markelewicz, MD

Chief Medical Officer

Experts on Boards

Bob Langer

Robert Langer, PhD

David H. Koch Institute Professor, MIT;
Founder of Moderna, BIND,
Momenta, AIR, others

Dr Laurie Glimcher

Laurie Glimcher, MD

Former President and CEO,
Dana-Farber Cancer Institute

Ron Levy, MD

Ron Levy, MD

Professor and Chief,
Division of Oncology,
Stanford School of Medicine

George Tsokos wearing a business suit

George Tsokos, MD

Professor of Medicine,
Beth Israel Deaconess
Medical Center

Shiv Pillai, PhD, in business attire

Shiv Pillai, PhD

Professor of Medicine,
Harvard Medical School and Massachusetts General Hospital

Steven Schnittman, MD and PhD, wearing a business suit

Steven Schnittman, MD, PhD

Infectious Disease Specialist;
Ex-NIH/Chief HIV Division;
Ex-VP BMS

Board of Directors

Miles Suk

Miles Suk

Chairman

Ian MacDonald

Anthony D. Eisenberg

Soo-Young Lee, Ph.D.

Our Collaborators

celltrion
AstraZeneca
Back To Top